Pacira BioSciences, Inc. (PCRX) › Operating IncomePacira BioSciences, Inc. (PCRX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$28.55M2010: -$22.71M2011: -$39.10M2012: -$49.30M2013: -$53.29M2014: -$5.17M2015: $9.46M2016: -$32.02M2017: -$24.94M2018: $15.91M2019: $10.48M2020: $46.35M2021: $89.92M2022: $60.02M2023: $87.67M2024: -$73.37M2025: $19.19M$19.19M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$19.19M+126.2%2024-$73.37M-183.7%2023$87.67M+46.1%2022$60.02M-33.3%2021$89.92M+94.0%2020$46.35M+342.3%2019$10.48M-34.2%2018$15.91M+163.8%2017-$24.94M+22.1%2016-$32.02M-438.7%2015$9.46M+283.1%2014-$5.17M+90.3%2013-$53.29M-8.1%2012-$49.30M-26.1%2011-$39.10M-72.2%2010-$22.71M+20.5%2009-$28.55M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share